Anticorps Monoclonal anti-MDM2

MDM2 Monoclonal Antibody for IF, IHC, WB, ELISA

Hôte / Isotype

Mouse / IgG2b

Réactivité testée

Humain, Lapin, rat, souris

Applications

WB, IP, IHC, IF, CoIP, ELISA

Conjugaison

Non conjugué

Publications

20

CloneNo.

2A6C9

N° de cat : 66511-1-Ig

Synonymes

Double minute 2 protein, hdm2, HDMX, MDM2, Oncoprotein Mdm2, p53 binding protein Mdm2

---

Galerie de données de validation

• 

  WB analysis of MCF-7 using 66511-1-Ig

  MCF-7 cells were subjected to SDS PAGE followed by western blot with 66511-1-Ig (MDM2 antibody) at dilution of 1:3000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of rat brain using 66511-1-Ig

  rat brain tissue were subjected to SDS PAGE followed by western blot with 66511-1-Ig (MDM2 antibody) at dilution of 1:3000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of mouse brain using 66511-1-Ig

  mouse brain tissue were subjected to SDS PAGE followed by western blot with 66511-1-Ig (MDM2 antibody) at dilution of 1:3000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of U-251 using 66511-1-Ig

  U-251 cells were subjected to SDS PAGE followed by western blot with 66511-1-Ig (MDM2 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours.

• 

  WB analysis using 66511-1-Ig

  Various lysates were subjected to SDS PAGE followed by western blot with 66511-1-Ig (MDM2 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of MCF-7 using 66511-1-Ig

  MCF-7 cells were subjected to SDS PAGE followed by western blot with 66511-1-Ig (MDM2 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of A549 using 66511-1-Ig

  A549 cells were subjected to SDS PAGE followed by western blot with 66511-1-Ig (MDM2 antibody) at dilution of 1:3000 incubated at room temperature for 1.5 hours.

• 

  IHC staining of human breast cancer using 66511-1-Ig

  Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 66511-1-Ig (MDM2 antibody) at dilution of 1:300 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human breast cancer using 66511-1-Ig

  Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 66511-1-Ig (MDM2 antibody) at dilution of 1:300 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human liver cancer using 66511-1-Ig

  Immunohistochemical analysis of paraffin-embedded human liver cancer tissue slide using 66511-1-Ig (MDM2 antibody) at dilution of 1:300 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human liver cancer using 66511-1-Ig

  Immunohistochemical analysis of paraffin-embedded human liver cancer tissue slide using 66511-1-Ig (MDM2 antibody) at dilution of 1:300 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IF Staining of HeLa using 66511-1-Ig

  Immunofluorescent analysis of (4% PFA) fixed HeLa cells using MDM2 antibody (66511-1-Ig, Clone: 2A6C9 ) at dilution of 1:800 and CoraLite®488-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L).

---

Applications testées

• Résultats positifs en WB: cellules MCF-7, cellules A549, cellules U-251, tissu cérébral de lapin, tissu cérébral de rat, tissu cérébral de souris
• Résultats positifs en IHC: tissu de cancer du sein humain, tissu de cancer du foie humain; il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
• Résultats positifs en IF: cellules HeLa,

Dilution recommandée

• Western Blot (WB): WB : 1:1000-1:6000
• Immunohistochimie (IHC): IHC : 1:150-1:600
• Immunofluorescence (IF): IF : 1:400-1:1600

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• WB: See 17 publications below
• IHC: See 3 publications below
• IF: See 2 publications below
• IP: See 2 publications below
• CoIP: See 2 publications below

Informations sur le produit

66511-1-Ig cible MDM2 dans les applications de WB, IP, IHC, IF, CoIP, ELISA et montre une réactivité avec des échantillons Humain, Lapin, rat, souris

• Réactivité: Humain, Lapin, rat, souris
• Réactivité citée: rat, Humain, souris
• Hôte / Isotype: Mouse / IgG2b
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: Peptide
• Nom complet: Mdm2 p53 binding protein homolog (mouse)
• Masse moléculaire calculée: 55 kDa
• Poids moléculaire observé: 40-55 kDa
• Numéro d’acquisition GenBank: NM_002392
• Symbole du gène: MDM2
• Identification du gène (NCBI): 4193
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par protéine A
• Tampon de stockage: PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

What is the cellular localization of MDM2?

MDM2 is predominantly localized in the nucleoplasm.

What is the tissue specificity of MDM2?

MDM2 is non-specific, expressing ubiquitously in the brain, heart, kidney, skin, and other tissues. Certain 

isoforms only express in cancerous cells and not normal tissue.

With what other molecules does MDM2 interact?

Most notably, the oncogene protein MDM2 regulates transcription factor p53 by binding its transcriptional 

activation domain and by E3-ubiquitin ligase activity. Ribosome proteins rpL5, rpL11, and rpL23 also bind to 

MDM2, inhibiting E3 ubiquitin ligase activity and promoting the p53 pathway.

What competes with MDM2 activity?

Nutilin-3 was designed to compete with MDM2 in binding with p53, inducing activation of the p53 pathway.

What is the role of ubiquitination in MDM2 activity?

While p53 is also affected by other post-translational modifications, its stability is determined by ubiquitination 

mediation of MDM2, suppressing p53 transcriptional regulation and leading to the proteosomal degradation of 

p53.

How is MDM2 associated with cancer?

MDM2 inhibits the activity of the tumor-suppressive protein p53, which serves as an important factor in 

promoting DNA repair or activating apoptotic pathways. Loss of p53 is associated with tumor development 

and growth.

What is the human ortholog of MDM2?

Human double-minute type 2 (HDM2)

In what cellular circumstances does the p53-MDM2 complex dissociate?

Cellular stress or DNA damage result in the phosphorylation and activation of p53. Phosphorylation also 

prevents p53-MDM2 interaction.

Where is the gene located?

Hdm2 is located on human 12q15.

Mdm2 is located on murine 10 D2.

PMIDs: 24309898, 29584707, 9840926, 28714398

Publications

Species	Application	Title
mouse	WB	Redox Biol; A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity.; Authors - Mengjie Xiao
human	WB,IF,IP	Cell Death Discov; hMOF induces cisplatin resistance of ovarian cancer by regulating the stability and expression of MDM2; Authors - Mingbo Cai
human	WB	Cell Death Discov; LASS2 enhances p53 protein stability and nuclear import to suppress liver cancer progression through interaction with MDM2/MDMX; Authors - Qingqing Zhao
human	CoIP	Oncogenesis; MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.; Authors - DongDong Tong
human	WB,IHC,IP	Int J Biol Sci; Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation.; Authors - Saiyan Bian
rat	IF	J Cell Mol Med; LncRNA MIAT enhances cerebral ischaemia/reperfusion injury in rat model via interacting with EGLN2 and reduces its ubiquitin-mediated degradation.; Authors - Suping Li